Stephane Pintat

Title: The Innovations of Stephane Pintat

Introduction

Stephane Pintat is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes related to autoimmune and inflammatory diseases. His work is characterized by a focus on innovative chemical formulations that have the potential to improve treatment options for various medical conditions.

Latest Patents

Stephane Pintat holds a patent for a compound known as tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate, or solvate thereof. This invention provides a pharmaceutical composition that includes the compound along with one or more pharmaceutically acceptable carriers and/or excipients. The compound is particularly useful for inhibiting the activity of a p38 MAP kinase enzyme, which plays a crucial role in the treatment of autoimmune or inflammatory diseases, as well as cell proliferative diseases.

Career Highlights

Stephane Pintat is associated with Macrophage Pharma Limited, where he continues to advance his research and development efforts. His work at the company has been instrumental in exploring new therapeutic avenues and enhancing the understanding of complex biological mechanisms.

Collaborations

Throughout his career, Stephane Pintat has collaborated with esteemed colleagues such as Stephen John Davies and David Festus Moffat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stephane Pintat's contributions to the field of pharmaceuticals highlight his commitment to advancing medical science through innovative compounds. His work has the potential to significantly impact the treatment of various diseases, showcasing the importance of research and collaboration in the pursuit of new medical solutions.